Guiee N. López-Castillo
Guiee N. López-Castillo has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Alan Carrasco-Carballo
Laboratorio de Elucidación y Síntesis en Química Orgánica, Centro de Química, Instituto de Ciencias, Benemérita Universidad Autónoma de Puebla, Puebla 72570, Mexico
3 shared publications - Jesús Sandoval-Ramírez
Laboratorio de Modificación y síntesis en Productos Naturales, Facultad de Ciencias Químicas, BUAP, Puebla 72570, Mexico
3 shared publications - Ana G. Cortes-Torres
Laboratorio de Elucidación y Síntesis en Química Orgánica, ICUAP-BUAP, Puebla 72570, Mexico
1 shared publication - Antonio Rosales-López
Laboratorio de Elucidación y Síntesis en Química Orgánica, Instituto de Ciencias, BUAP, Puebla 72570, México
1 shared publication - Arnoldo Wong-Villarreal
División Agroalimentaria, Universidad Tecnológica de la Selva, Ocosingo, Chiapas, Mexico
1 shared publication - Beatriz Eugenia Baca
Laboratorio de la Interacción Bacteria-planta, Centro de Investigaciones en Ciencias Microbiológicas, Instituto de Ciencias, Benemérita Universidad Autónoma de Puebla, Puebla, Mexico
1 shared publication
Latest Publications
- Open Access
- 6 August 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (16) , 8588
Correlation between Molecular Docking and the Stabilizing Interaction of HOMO-LUMO: Spirostans in CHK1 and CHK2, an In Silico Cancer Approach
Checkpoint kinases 1 and 2 (CHK1 and CHK2) are enzymes that are involved in the control of DNA damage. At the present time, these enzymes are some of the most important targets in the fight against cancer since their inhibition produces cytotoxic effects in carcinogenic cells. This paper proposes the use of spirostans (Sp), natural compounds, as possible inhibitors of the enzymes CHK1 and CHK2 from an in silico analysis of a database of 155 molecules (S5). Bioinformatics studies of molecular docking were able to discriminate between 13 possible CHK1 inhibitors, 13 CHK2 inhibitors and 1 dual inhibitor for both enzymes. The administration, distribution, metabolism, excretion and toxicity (ADMETx) studies allowed a prediction of the distribution and metabolism of the potential inhibitors in the body, as well as determining the excretion routes and the appropriate administration route. The best inhibition candidates were discriminated by comparing the enzyme-substrate interactions from 2D diagrams and molecular docking. Specific inhibition candidates were obtained, in addition to studying the dual inhibitor candidate and observing their stability in dynamic molecular studies. In addition, Highest Occupied Molecular Orbital—Lowest Unoccupied Molecular Orbital (HOMO-LUMO) interactions were analyzed to study the stability of interactions between the selected enzymes and spirostans resulting in the predominant gaps from HOMOCHKs to LUMOSp (Highest Occupied Molecular Orbital of CHKs—Lowest Unoccupied Molecular Orbital of spirostan). In brief, this study presents the selection inhibitors of CHK1 and CHK2 as a potential treatment for cancer using a combination of molecular docking and dynamics, ADMETx predictons, and HOMO-LUMO calculation for selection.
- 6 August 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (16) , 8588
Open AccessCorrelation between Molecular Docking and the Stabilizing Interaction of HOMO-LUMO: Spirostans in CHK1 and CHK2, an In Silico Cancer Approach
Checkpoint kinases 1 and 2 (CHK1 and CHK2) are enzymes that are involved in the control of DNA damage. At the present time, these enzymes are some of the most important targets in the fight against cancer since their inhibition produces cytotoxic effects in carcinogenic cells. This paper proposes the use of spirostans (Sp), natural compounds, as possible inhibitors of the enzymes CHK1 and CHK2 from an in silico analysis of a database of 155 molecules (S5). Bioinformatics studies of molecular docking were able to discriminate between 13 possible CHK1 inhibitors, 13 CHK2 inhibitors and 1 dual inhibitor for both enzymes. The administration, distribution, metabolism, excretion and toxicity (ADMETx) studies allowed a prediction of the distribution and metabolism of the potential inhibitors in the body, as well as determining the excretion routes and the appropriate administration route. The best inhibition candidates were discriminated by comparing the enzyme-substrate interactions from 2D diagrams and molecular docking. Specific inhibition candidates were obtained, in addition to studying the dual inhibitor candidate and observing their stability in dynamic molecular studies. In addition, Highest Occupied Molecular Orbital—Lowest Unoccupied Molecular Orbital (HOMO-LUMO) interactions were analyzed to study the stability of interactions between the selected enzymes and spirostans resulting in the predominant gaps from HOMOCHKs to LUMOSp (Highest Occupied Molecular Orbital of CHKs—Lowest Unoccupied Molecular Orbital of spirostan). In brief, this study presents the selection inhibitors of CHK1 and CHK2 as a potential treatment for cancer using a combination of molecular docking and dynamics, ADMETx predictons, and HOMO-LUMO calculation for selection.
- Open Access
Evaluation of the Plant Growth Regulator SPGP4 in Agricultural Crops: A Case Study in Oaxaca, México
The search for new plant growth regulators is a cornerstone of agricultural research; however, laboratory studies rarely go on to be evaluated in the field. This is because greater production is required, as well as longer studies. Particularly, brassinosteroids present these difficulties, and although they have been evaluated in crops with good results, their high production cost gives rise to the search for new alternatives. 22-Oxocholestanes such as SPGP4, previously used in silico and in vitro studies, have shown great potential, so their evaluation in crops grown from native seeds from the study region becomes of interest. Based on these data, SPGP4 was evaluated under crop conditions in three agricultural plots located on the Isthmus of Tehuantepec region, Oaxaca, México. The seeds were treated with a 0.5 mg/L aqueous solution of the 22-Oxocholestane compound SPGP4 by imbibition one night before sown. Later, 45 days after sowing, a solution of 0.5 mg/L at a rate of 200 L per hectare was applied. At the production level, the bean harvest showed an increase in the range of 21.0–38.1%, and the corn harvest increased between 22 and 32%. In addition, the latter also demonstrated an increase in biomass production, given the increase in diameter and height observed in the corn plant. This indicates that SPGP4 functions as a regulator of plant growth at the crop level to increase both seed and biomass production.
Open AccessEvaluation of the Plant Growth Regulator SPGP4 in Agricultural Crops: A Case Study in Oaxaca, México
The search for new plant growth regulators is a cornerstone of agricultural research; however, laboratory studies rarely go on to be evaluated in the field. This is because greater production is required, as well as longer studies. Particularly, brassinosteroids present these difficulties, and although they have been evaluated in crops with good results, their high production cost gives rise to the search for new alternatives. 22-Oxocholestanes such as SPGP4, previously used in silico and in vitro studies, have shown great potential, so their evaluation in crops grown from native seeds from the study region becomes of interest. Based on these data, SPGP4 was evaluated under crop conditions in three agricultural plots located on the Isthmus of Tehuantepec region, Oaxaca, México. The seeds were treated with a 0.5 mg/L aqueous solution of the 22-Oxocholestane compound SPGP4 by imbibition one night before sown. Later, 45 days after sowing, a solution of 0.5 mg/L at a rate of 200 L per hectare was applied. At the production level, the bean harvest showed an increase in the range of 21.0–38.1%, and the corn harvest increased between 22 and 32%. In addition, the latter also demonstrated an increase in biomass production, given the increase in diameter and height observed in the corn plant. This indicates that SPGP4 functions as a regulator of plant growth at the crop level to increase both seed and biomass production.
- Open Access
- 16 June 2023
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 45 (6) , 5164-5179
Cymbopogon citratus Essential Oil: Extraction, GC–MS, Phytochemical Analysis, Antioxidant Activity, and In Silico Molecular Docking for Protein Targets Related to CNS
This study analyzed the chemical composition of Cymbopogon citratus essential oil from Puebla, México, assessed its antioxidant activity, and evaluated in silico protein–compound interactions related to central nervous system (CNS) physiology. GC–MS analysis identified myrcene (8.76%), Z-geranial (27.58%), and E-geranial (38.62%) as the main components, with 45 other compounds present, which depends on the region and growing conditions. DPPH and Folin–Ciocalteu assays using the leaves extract show a promising antioxidant effect (EC50 = 48.5 µL EO/mL), reducing reactive oxygen species. The bioinformatic tool SwissTargetPrediction (STP) shows 10 proteins as potential targets associated with CNS physiology. Moreover, protein–protein interaction diagrams suggest that muscarinic and dopamine receptors are related to each other through a third party. Molecular docking reveals that Z-geranial has higher binding energy than M1 commercial blocker and blocks M2, but not M4 muscarinic acetylcholine receptors, whereas β-pinene and myrcene block M1, M2, and M4 receptors. These actions may positively affect cardiovascular activity, memory, Alzheimer’s disease, and schizophrenia. This study highlights the significance of understanding natural product interactions with physiological systems to uncover potential therapeutic agents and advanced knowledge on their benefits for human health.
- 16 June 2023
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 45 (6) , 5164-5179
Open AccessCymbopogon citratus Essential Oil: Extraction, GC–MS, Phytochemical Analysis, Antioxidant Activity, and In Silico Molecular Docking for Protein Targets Related to CNS
This study analyzed the chemical composition of Cymbopogon citratus essential oil from Puebla, México, assessed its antioxidant activity, and evaluated in silico protein–compound interactions related to central nervous system (CNS) physiology. GC–MS analysis identified myrcene (8.76%), Z-geranial (27.58%), and E-geranial (38.62%) as the main components, with 45 other compounds present, which depends on the region and growing conditions. DPPH and Folin–Ciocalteu assays using the leaves extract show a promising antioxidant effect (EC50 = 48.5 µL EO/mL), reducing reactive oxygen species. The bioinformatic tool SwissTargetPrediction (STP) shows 10 proteins as potential targets associated with CNS physiology. Moreover, protein–protein interaction diagrams suggest that muscarinic and dopamine receptors are related to each other through a third party. Molecular docking reveals that Z-geranial has higher binding energy than M1 commercial blocker and blocks M2, but not M4 muscarinic acetylcholine receptors, whereas β-pinene and myrcene block M1, M2, and M4 receptors. These actions may positively affect cardiovascular activity, memory, Alzheimer’s disease, and schizophrenia. This study highlights the significance of understanding natural product interactions with physiological systems to uncover potential therapeutic agents and advanced knowledge on their benefits for human health.